Seikagaku Corp
TSE:4548
Intrinsic Value
Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. The company i... [ Read More ]
The intrinsic value of one Seikagaku Corp stock under the Base Case scenario is 832.56 JPY. Compared to the current market price of 737 JPY, Seikagaku Corp is Undervalued by 11%.
Valuation Backtest
Seikagaku Corp
Run backtest to discover the historical profit from buying and selling Seikagaku Corp stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Seikagaku Corp
Current Assets | 42.8B |
Cash & Short-Term Investments | 22.1B |
Receivables | 8B |
Other Current Assets | 12.6B |
Non-Current Assets | 37.1B |
Long-Term Investments | 17.5B |
PP&E | 14B |
Intangibles | 3.4B |
Other Non-Current Assets | 2.2B |
Current Liabilities | 5.9B |
Accounts Payable | 1.1B |
Accrued Liabilities | 330m |
Short-Term Debt | 300m |
Other Current Liabilities | 4.2B |
Non-Current Liabilities | 2.2B |
Long-Term Debt | 59m |
Other Non-Current Liabilities | 2.2B |
Earnings Waterfall
Seikagaku Corp
Revenue
|
34.7B
JPY
|
Cost of Revenue
|
-17.2B
JPY
|
Gross Profit
|
17.5B
JPY
|
Operating Expenses
|
-16.5B
JPY
|
Operating Income
|
1B
JPY
|
Other Expenses
|
274m
JPY
|
Net Income
|
1.3B
JPY
|
Free Cash Flow Analysis
Seikagaku Corp
Profitability Score
Profitability Due Diligence
Seikagaku Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Seikagaku Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Seikagaku Corp's solvency score is 98/100. The higher the solvency score, the more solvent the company is.
Score
Seikagaku Corp's solvency score is 98/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Seikagaku Corp
According to Wall Street analysts, the average 1-year price target for Seikagaku Corp is 1 950 JPY .
Shareholder Return
Price
Seikagaku Corp
Average Annual Return | -6.71% |
Standard Deviation of Annual Returns | 7.48% |
Max Drawdown | -40% |
Market Capitalization | 40.2B JPY |
Shares Outstanding | 56 105 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 913 full-time employees. The company went IPO on 2004-03-23. The firm operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.
Contact
IPO
Employees
Officers
The intrinsic value of one Seikagaku Corp stock under the Base Case scenario is 832.56 JPY.
Compared to the current market price of 737 JPY, Seikagaku Corp is Undervalued by 11%.